SCHEMBL23920994

SCHEMBL23920994

CN(C)c1ccc(NC(=O)CSc2nc3c(=O)[nH]c(N)nc3n2CCO)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.48
GAA P10253 3/20 0.48
THRB P10828 1/20 0.48
ALDH1A1 P00352 9/20 0.47
L3MBTL1 Q9Y468 4/20 0.46
POLB P06746 4/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 3/20 0.43
MAPK1 P28482 2/20 0.43
NPSR1 Q6W5P4 2/20 0.42
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920992 0.89 HDAC3 (0.40) MAPTGAATHRBALDH1A1L3MBTL1
SCHEMBL23921082 0.88 PKM (0.52) MAPTGAAALDH1A1L3MBTL1POLB
SCHEMBL23921073 0.80 MEN1 (0.42) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL21396435 0.79 PNP (0.42) ALDH1A1L3MBTL1CYP3A4CYP2C9CYP2C19
SCHEMBL23921227 0.78 ALDH1A1 (0.47) MAPTALDH1A1KMT2ACYP3A4CYP2C9
SCHEMBL23921107 0.78 PNP (0.47) GAAALDH1A1POLBSMN1; SMN2MAPK1
SCHEMBL21396481 0.78 MEN1 (0.44) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL23921094 0.77 PNP (0.48) ALDH1A1KMT2AHTTUSP2HPGD
SCHEMBL21396394 0.77 PNP (0.51) MAPTALDH1A1USP2HPGDHSD17B10
SCHEMBL23920856 0.77 CYP3A4 (0.56) GAAALDH1A1POLBCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 MAPT 4120/4885GAA 592/4885THRB 3331/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A MAPT 4036/4885GAA 627/4885THRB 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.